Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 28(Granted Patents)

Location History:

Niiza, JA (1976)
Tokorozawa, JP (1980 - 1998)
Tokorozawa-shi, Saitama, JP (2010)
Saitama, JP (1978 - 2012)

Company Filing History:

5 out of 677

Eisai Company, Limited

Muromachi Chemical Co., Ltd.

patents

4. 1 out of 15

Asama Chemical Co., Ltd.

Muromachi Kagaku Kogyo Kaisha, Ltd.

patent

7. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1976-2012

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8287911 - Endotoxin adsorbent for the prevention and treatment of autoimmune diseases (2012-10-16),

2. 7799347 - Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases (2010-09-21),

3. 7150870 - Anti-tumor agent (2006-12-19),

4. 6506388 - Immunomodulator, immunomodulator food (2003-01-14),

5. 5780509 - Compound bearing two, 2,6-diiodophenol-4-YL groups and diagnostic drug (1998-07-14),

6. 4490362 - Immunopotentiator comprising the B chain of ricin as an active ingredient (1984-12-25),

7. 4459287 - Immunopotentiator containing recin (1984-07-10),

8. 4414201 - Immunopotentiator containing abrin (1983-11-08),

9. 4208426 - Pyranochromone derivatives and therapeutic composition comprising same (1980-06-17),

10. 4130648 - 5-Fluorouracil derivatives and antitumor preparations containing the same (1978-12-19),

11. 3987164 - Method for prevention of pseudomonas aeruginosa infections (1976-10-19),

Title: Hiroshi Shionoya: Innovator in Autoimmune Disease Treatment

Introduction

Hiroshi Shionoya is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of 11 patents to his name, Shionoya's work focuses on innovative solutions that address critical health issues.

Latest Patents

One of Shionoya's latest patents is an endotoxin adsorbent designed for the prevention and treatment of autoimmune diseases. Research indicates that the abnormal absorption of endotoxin in the gastrointestinal tract is linked to the pathogenesis of autoimmune diseases such as rheumatoid arthritis. In animal models, it has been observed that removing endotoxin can improve arthritis symptoms. This invention provides a safe endotoxin-adsorbent capable of effectively removing endotoxin from the gastrointestinal tract. By utilizing a non-digestible and non-absorbable endotoxin-adsorbent with a high binding capacity, it is possible to prevent and treat autoimmune diseases like rheumatoid arthritis.

Career Highlights

Throughout his career, Hiroshi Shionoya has worked with notable companies, including Eisai Company, Limited. His innovative approaches have garnered attention and respect within the medical community.

Collaborations

Shionoya has collaborated with esteemed colleagues such as Sadaichi Iwashita and Hitoshi Takeuchi. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Hiroshi Shionoya's work in developing endotoxin adsorbents represents a significant advancement in the treatment of autoimmune diseases. His innovative spirit and dedication to improving health outcomes continue to inspire the medical field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.